Virox™ is pleased to announce that several of our Accelerated Hydrogen Peroxide® (AHP®) wipe formulations have been validated by independent testing and proven efficacious against SARS-CoV- 2, the virus that causes COVID-19 disease. As industry leaders in infection prevention, our mission is to ensure our customers are protected against the threat of emerging disease outbreaks in all of the markets we serve.
As COVID-19 began to spread worldwide, public health officials issued recommendations to practice physical distancing, regular hand hygiene and cleaning and disinfection to prevent the spread of the SARS-CoV-2 virus. In the event of outbreaks caused by emerging viral pathogens, both the EPA and Health Canada rely on their Emerging Viral Pathogen policies to determine the expected effectiveness of disinfectants against a newly identified virus. All Virox AHP-based formulations meet the criteria for emerging viral pathogens, and can be found on the list of approved disinfectants for both Canada and the United States for use against SARS-CoV-2. The recent testing provides an added layer of confidence that AHP-based formulations have directly demonstrated the ability to kill SARS-CoV-2 and will be submitted to both the EPA and Health Canada for review and approval at which time product labels and marketing materials will be updated.